Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

NSCLC 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Cisplatin 117 Oxaliplatin 111 Fluorouracil 100 Capecitabine 90 Docetaxel 69 Leucovorin 60 Irinotecan 57 Paclitaxel 49 S 1 (combination) 38 pembrolizumab 35 Trastuzumab 31 Radiotherapy 25 Bevacizumab 20 Nivolumab 19 Epirubicin 19 titanium silicide 18 Surgical Procedures, Operative 17 Carboplatin 17 Ramucirumab 16 Cetuximab 15 Gastrectomy 13 apatinib 12 Everolimus 12 Gemcitabine 11 Albumin-Bound Paclitaxel 10 Neoadjuvant Therapy 8 Folfox protocol 8 Drug Therapy 8 Chemotherapy, Adjuvant 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × Liquid Biopsy × Clear all

NCT04253106 2024-09-23

LISA-HDGC

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡